$2.120
-0.039 (-1.85%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
GRCE 相似圖表分析預測
Alphio's GRCE stock price prediction model matches the current Grace Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.12 (-0.10%). The 1-week path is $2.08 (-1.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Grace Therapeutics, Inc 股票嗎？
Grace Therapeutics, Inc. (GRCE) is currently not a strong buy. The stock is priced at $2.12, significantly below its analyst price targets of $4 and $8, indicating potential upside. However, the company has faced recent challenges, including a 49% drop in stock price due to an FDA rejection of its drug application, which poses a significant risk. The current RSI of 39.7 suggests the stock is nearing oversold territory, but the negative sentiment from the FDA rejection and the projected net loss of $15.79 million in Q1 2027 raises concerns about immediate investment viability.
GRCE 股價於 Friday 收在 $2.12，此前下跌 -1.85%
Grace Therapeutics, Inc (GRCE) last closed at $2.12, losing -1.85%. These facts feed the 1-day and 1-week GRCE price prediction above.
預測驅動因素
Grace Therapeutics, Inc（GRCE）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 GRCE 最接近的股票，依相似度排序。
GRCE 季節性分析
Historically the probability of a positive August return for GRCE is 0.00%. March offers the highest probability of a positive month at 66.67%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
GRCE 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Aug 2026 | $3.47 | $4.06 | $4.67 | +91.38% |
| Sep 2026 | $2.90 | $3.48 | $3.61 | +63.97% |
| Oct 2026 | $3.40 | $3.61 | $4.18 | +70.43% |
| Nov 2026 | $3.02 | $3.33 | $3.80 | +56.89% |
| Dec 2026 | $2.55 | $3.00 | $3.03 | +41.45% |
2026 年，Grace Therapeutics, Inc（GRCE）預計區間為 $2.55 至 $4.67。
Grace Therapeutics, Inc 2026 年月度預測
2026 年 Aug，Grace Therapeutics, Inc 預計均價 $4.06，最低 $3.47，最高 $4.67。
2026 年 Sep，Grace Therapeutics, Inc 預計均價 $3.48，最低 $2.90，最高 $3.61。
2026 年 Oct，Grace Therapeutics, Inc 預計均價 $3.61，最低 $3.40，最高 $4.18。
2026 年 Nov，Grace Therapeutics, Inc 預計均價 $3.33，最低 $3.02，最高 $3.80。
2026 年 Dec，Grace Therapeutics, Inc 預計均價 $3.00，最低 $2.55，最高 $3.03。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。